NEW YORK, June 14, 2007 -- Jefferies & Company, Inc., the principal operating subsidiary of Jefferies Group, Inc. (NYSE: JEF), today announced that the Firm will hold its annual Healthcare Conference on June 26-28 in New York City. This year the Jefferies Healthcare Conference combines all of the Firm’s healthcare sub-sector areas of focus: biotechnology, specialty pharmaceuticals, medical devices and healthcare services. Synergies created by this combined event are intended to provide the Firm's institutional clients with broader access to leading companies in these areas.
“The number and variety of presenting companies at our 2007 healthcare conference demonstrates the extensive reach of Jefferies' healthcare effort,” commented Raymond J. Minella, Managing Director and Head of Healthcare Investment Banking at Jefferies. "We will also have broad representation from companies around the world, befitting the global nature of the sector and our practice. This event is an ideal setting for market participants and industry leaders to converge and share viewpoints."
The conference will showcase more than 170 public and private companies and industry experts to address the areas of biotechnology, CROs, healthcare services, healthcare IT, managed care, medical devices & diagnostics, and specialty pharmaceuticals.
An audio webcast of each presentation, both live and replay, will be available at the discretion of the presenting companies, and will be accessible at www.jefferies.com.
For further information about the Jefferies Healthcare Conference, please contact your Jefferies representative or Jodi Pulman (212-284-2581, jpulman@Jefferies.com).
About Jefferies
Jefferies, a global investment bank and institutional securities firm, has served growing and mid-sized companies and their investors for 45 years. Headquartered in New York, with more than 25 offices around the world, Jefferies provides clients with capital markets and financial advisory services, institutional brokerage, securities research and asset management. The firm is a leading provider of trade execution in equity, high yield, convertible and international securities for institutional investors and high net worth individuals. Jefferies & Company, Inc. is the principal operating subsidiary of Jefferies Group, Inc. (NYSE: JEF; www.jefferies.com).
For Media Inquires, please contact:
Tom Tarrant
Jefferies & Company, Inc.
203 708 5989
ttarrant@Jefferies.com
Aimee Baxter
CJP Communications
212 279 3115 ext. 225
abaxter@cjpcom.com